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The Brahma (Brm) complex of Drosophila melanogaster is a SWI/SNF-related chromatin remodeling complex required to correctly
maintain proper states of gene expression through ATP-dependent effects on chromatin structure. The SWI/SNF complexes are comprised of
8–11 stable components, even though the SWI2/SNF2 (BRM, BRG1, hBRM) ATPase subunit alone is partially sufficient to carry out
chromatin remodeling in vitro. The remaining subunits are required for stable complex assembly and/or proper promoter targeting in vivo. Our
data reveals that SNR1 (SNF5-Related-1), a highly conserved subunit of the Brm complex, is required to restrict complex activity during the
development of wing vein and intervein cells, illustrating a functional requirement for SNR1 in modifying whole complex activation functions.
Specifically, we found that snr1 and brm exhibited opposite mutant phenotypes in the wing and differential misregulation of genes required for
vein and intervein cell development, including rhomboid, decapentaplegic, thick veins, and blistered, suggesting possible regulatory targets for
the Brm complex in vivo. Our genetic results suggest a novel mechanism for SWI/SNF-mediated gene repression that relies on the function of a
‘core’ subunit to block or shield BRM (SWI2/SNF2) activity in specific cells. The SNR1-mediated repression is dependent on cooperation with
histone deacetylases (HDAC) and physical associations with NET, a localized vein repressor.
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During Drosophila development, elaboration of the final
adult structures is determined by the proper sequential
regulation of specific genes in each cell through epigenetic
mechanisms directing both the initiation and maintenance of
transcription. An important paradigm of epigenetic regula-
tion is that ATP-dependent chromatin remodeling is required
to help establish and maintain patterns of gene expression
(both activation and repression) through disruption of DNA-
histone contacts and higher order chromatin folding. Thus,
chromatin remodeling may be viewed as influencing gene0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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access of regulatory factors to nucleosomal DNA.
Among the best-characterized ATP-dependent chromatin
remodeling complexes, the 1.2 MDa SWI/SNF complex first
identified in yeast, with functional counterparts found in flies
(Brahma [Brm] complex) and mammals (Brg1/hBrm com-
plexes), allows for greater accessibility to nucleosomal DNA
(Peterson, 2002; Smith et al., 2003; Vignali et al., 2000).
Genetic and biochemical studies have revealed requirements
for the complex in a diverse array of cellular functions,
including the activation and repression of gene transcription,
controlling the progression of the cell cycle, and facilitating
intracellular retrovirus transport and chromosomal integra-
tion (Becker and Horz, 2002; Katsani et al., 2003; Tsu-
kiyama, 2002). The SWI/SNF complexes appear to be
targeted or recruited to specific loci through associations
between complex components and acidic domains within
transcriptional activators/repressors (Kadam et al., 2000;
Neely et al., 1999; Peterson and Logie, 2000; Peterson and
Workman, 2000).
Although the multimeric SWI/SNF complexes are large
(8–11 subunits), full in vitro chromatin remodeling activity
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complished by as few as four reconstituted mammalian
subunits, INI1/BAF47, BAF15, BAF170, and BRG1, sug-
gesting that these proteins form the functional catalytic core
of the complex (Phelan et al., 1999). This conclusion has
been challenged by recent work (Collins et al., 1999; Zraly
et al., 2003); further, some conserved core subunits function
in vivo to constrain or limit chromatin remodeling activities
of the complex (Marenda et al., 2003). The SWI2/SNF2
subunit provides the only clearly established catalytic activ-
ity of the SWI/SNF complexes, and it is partially sufficient
for in vitro chromatin remodeling (Laurent et al., 1993;
Muchardt and Yaniv, 1993; Phelan et al., 1999; Richmond
and Peterson, 1996); thus, the remaining subunits are
thought to mainly assist in providing target specificity
through recruitment by transcriptional activators, to assist
in stable complex assembly, and/or to modulate complex
functions, perhaps by mediating complex interactions at the
promoter, allowing for flexibility in interaction strength
(Neely et al., 2002).
The Drosophila SWI/SNF-related Brahma (Brm) com-
plex is strongly conserved, both structurally and functionally,
with its mammalian Brg1/hBrm/BAF/PBAF complex coun-
terparts (Martens and Winston, 2003). Disruptions of genes
encoding several subunits have revealed important roles for
the metazoan SWI/SNF complexes in controlling a variety of
distinct developmental pathways, with loss-of-function
mutations leading to alterations in cell fate (Simon and
Tamkun, 2002; Tamkun, 1995) and aggressive cancers
(Cairns, 2001; Muchardt and Yaniv, 2001; Roberts et al.,
2002). Based largely on genetic studies of the fly Brm
complex and mouse knockouts of the INI1/BAF47, BRG1,
and hBRM genes, it appears that the metazoan complex
subunits are all encoded by essential genes; however, their
specific roles in modulating or contributing to global com-
plex functions are not well resolved. Although the develop-
ment of some tissues may be sensitive to a quantitative
threshold of functional SWI/SNF complexes, in many cases,
complete removal of a subunit impacts a wide array of target
genes, leading to a catastrophic loss of viability, except in
those cases where a specific subunit was required for only a
subset of complex activities. The most striking example
involves the highly conserved metazoan SNF5-related sub-
unit, known as SNR1/BAP45 in flies (Dingwall et al., 1995),
and INI1/hSNF5/BAF47 in mammals (Kalpana et al., 1994).
Although the genes encoding these subunits are essential in
both flies and mammals (Dingwall et al., 1995; Guidi et al.,
2001; Klochendler-Yeivin et al., 2000; Roberts et al., 2000),
disruptions have been directly associated with defects in
tissue development (Marenda et al., 2003; Zraly et al., 2003),
as well as highly penetrant and aggressive rhabdosarcomas
and T cell lymphomas (Roberts et al., 2002; Sevenet et al.,
1999a; Versteege et al., 2002). Moreover, the yeast SNF5
subunit is important for complex assembly and it has been
directly associated with target promoter specificity (Geng et
al., 2001; Laurent et al., 1991; Neely et al., 2002).Mutations in some Brm complex genes display broad
developmental defects affecting a variety of tissues, includ-
ing both specific wing vein patterning defects as well as
global effects on wing size (Collins et al., 1999; Elfring et al.,
1998). Genetic interaction and somatic clone analyses of
Brm complex genes using null alleles have provided impor-
tant, though limited, understanding of the relative contribu-
tions of individual subunits to overall Brm complex
functions, as the genes encoding the components are all
essential and perdurance of stably incorporated proteins may
mask specific mutant phenotypes (Elfring et al., 1998; Zraly
et al., 2003). Moreover, loss of one SWI/SNF complex
component may result in complex instability, leading to
widespread transcriptional defects (Geng et al., 2001; Lau-
rent and Carlson, 1992; Laurent et al., 1991; Peterson and
Herskowitz, 1992; Yoshinaga et al., 1992).
We previously reported the initial characterization of the
conditional Drosophila snr1E1 temperature-sensitive allele
that displayed multiple mutant phenotypes, including the
appearance of extra wing veins (Marenda et al., 2003). The
snr1E1 mutation causes a single amino acid substitution
(G256D) in a nearly invariant glycine residue among
SNF5-family proteins within the highly conserved repeat 2
region, implicated in a variety of protein interactions. The
SNR1E1 protein is assembled into Brm complexes at both the
permissive and restrictive temperatures, and it co-immuno-
precipitates with BRM and OSA in protein extracts prepared
from early pupae (Marenda et al., 2003), indicating that Brm
complexes are forming in this mutant background at a
relatively late stage of development that coincides with
important final wing patterning events (Bier, 2000; Sturte-
vant and Bier, 1995). The snr1E1 phenotypes are sensitive to
both temperature of incubation and snr1 gene dose, indicat-
ing that the phenotypes specifically result from compromised
or impaired (loss of) SNR1 function, rather than complete
disruption of Brm complex activities. We believe that this is
because there are different effects of complete loss of the
functional complexes (as is the case of protein nulls that may
reduce total complex number by half), and those mutations
that produce a stable protein product, thus allowing com-
plexes to form and bind their targets, but then are defective in
some other function of the complex. Importantly, the dom-
inant extra vein phenotype associated with snr1E1 was
rescued by increasing wild-type genomic copies of the
snr1 gene, and was enhanced by reducing snr1 copy via a
null allele, indicating that in the context of wing vein
patterning, the snr1E1 mutation mimics a loss-of-function
effect (Marenda et al., 2003). While hypomorphic mutations
in most Brm complex subunits enhanced the severity of the
snr1E1 extra vein phenotype, loss-of-function mutations in
brm suppressed the extra vein phenotype, initially suggesting
that SNR1 functions to modulate Brm complex activity in
specific cells during development of the wing veins (Mar-
enda et al., 2003).
The brm gene encodes the catalytic ATPase subunit of the
Brm complex, and it is a functional counterpart of the yeast
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dominant-negative form of brm defective for ATP hydrolysis
(brmK804R) also shows an effect on wing vein patterning with
the loss of distal structures of the L5 vein (Elfring et al.,
1998; Collins et al., 1999). The BRMK804R protein competes
with wild-type BRM for assembly into Brm complexes, and
the lethality associated with expression of brmK804R
increases as wild-type BRM protein decreases, indicating
that this allele also mimics a loss-of-function brm effect
(Elfring et al., 1998). What makes the brmK804R allele
particularly attractive for use in our study is that similar to
SNR1E1, the BRMK804R protein is assembled into Brm
complexes; therefore, the resulting snr1 and brm mutant
phenotypes and genetic interactions reflect the incorporation
of defective subunits into the Brm complex with the resultant
loss of specific subunit functions rather than diminished
stability or synthesis of the entire Brm complex.
In the context of wing patterning, dominant-negative
BRMK804R and SNR1E1 proteins are stably incorporated into
Brm complexes where they elicit specific, though opposite,
defects due to reduced or impaired functions indicating that
for these particular phenotypes, proper formation of Brm
complexes that incorporate defective subunits is necessary
(Armstrong et al., 2002; Elfring et al., 1998; Marenda et al.,
2003). Importantly, these phenotypic effects are not observed
in brm and snr1 null alleles alone. In fact, previously
reported analyses of null alleles and somatic clones of both
brm and snr1 did not reveal any significant effects on wing
patterning, perhaps due to extended perdurance of the gene
products or stability of previously assembled complexes
(Brizuela et al., 1994; Dingwall et al., 1995; Elfring et al.,
1998; Zraly et al., 2003).
A postulate of SWI/SNF complex function is that the
complex is recruited to specific in vivo targets by activator or
repressor proteins to facilitate factor binding—and conse-
quently activation or repression that can be stably main-
tained—through ATP-dependent chromatin remodeling
(Peterson and Workman, 2000; Vignali et al., 2000). In
addition to clearly defined roles in gene activation, recent
work has indicated that the yeast SWI/SNF complex can
directly repress the SER3 gene in an SNF2/SWI2-dependent
manner, although other complex subunits appear to be
dispensable for this function (Martens and Winston, 2002).
A nonexclusive possibility is that the differential expression
of specific target genes may be regulated by shielding
chromatin domains from chromatin remodeling activities,
thus blocking SWI/SNF activating potential (Peterson,
2002). Our data suggests an intriguing third possibility, in
that conserved core subunits of the SWI/SNF (Brm) complex
might directly contribute to constraining complex activities
through sequestering the ATP-dependent activating poten-
tial. Thus, one of the most intriguing and challenging issues
is how specific in vivo chromatin remodeling complex
targets are selected and regulated.
In order to address these various possibilities, we have
taken advantage of the conditional and dosage-sensitivenature of our snr1E1 wing phenotypes, the availability of
characterized mutations and dominant-negative versions of
several Brm complex genes, and the well-defined develop-
mental pathways that govern the patterning of the Drosoph-
ila wings to help define functions of SNR1 within the Brm
complex and to identify candidate targets of the complex
that are biologically significant. As a consequence of the
stereotyped pattern in which the developing wing veins
occur, slight defects that affect this pattern are easily
recognized. There exist a large number of mutants that
affect wing vein patterning, and the cell signaling cascades
that govern specific gene expression in wing vein and
intervein tissues have been well-characterized. In this report,
we have taken advantage of the reciprocal mutant-reduced
function phenotypes associated with a dominant-negative
alleles of brm and snr1, and shown genetically that the
SNR1 subunit constrains the gene activation functions of
the Brm complex in both vein and intervein cells, and that
loss of this functional shielding leads to the misexpression
of a variety of vein regulatory genes. This analysis revealed
that genes previously identified as important for vein
specification and maintenance, including rhomboid, decap-
entaplegic, and thick veins, may likely be direct targets for
Brm complex regulation. Our genetic and protein interac-
tion analyses suggest that the localized vein repressor net
interacts with snr1 to regulate expression of rhomboid, and
that ATPase-dependent functions of the Brm complex are
not required for the repression of rhomboid in intervein
cells. In contrast to previous models of Brm complex
functions in gene repression that depend on BRM (SWI2/
SNF2) subunit ATPase functions (Martens and Winston,
2002; Pal et al., 2003), our results suggest another possible
mechanism to control Brm (SWI/SNF) complex activation
functions through shielding or blocking chromatin remod-
eling activities.Materials and methods
Fly stocks and crosses
All stocks were maintained on standard cornmeal medium
at 18jC, except for snr1E1/TM6B flies, which were main-
tained at 29jC. All alleles and stocks used are as described in
Flybase (http://flybase.bio.indiana.edu), with the following
exceptions: snr1E1 (Marenda et al., 2003), gpp61A, gppXXV,
gpp94A (G. Shanower, personal communication).
Unless otherwise indicated, genetic interaction tests were
carried out using snr1E1/TM6B females crossed to males
harboring mutations of interest. Biomass crosses were per-
formed at 18jC and wing phenotype crosses were performed
at 18jC or 29jC. Wings were examined for enhancement or
suppression of the snr1E1 wing phenotype based on com-
parison to siblings. When the mutation of interest was on the
X chromosome, virgin females of the appropriate genotype
were mated to male snr1E1/TM6B flies and examined as
Fig. 1. Wing phenotypes resulting from diminished snr1 and brm function.
(A) Wild-type wing showing longitudinal wing veins (L2, L3, L4, and L5),
the anterior cross-vein (acv) and the posterior cross-vein (pcv). (B)
Heterozygous snr1E1/+ mutant wings show a weak extra vein extending
distally from the pcv. (C–D) Strong heteroallelic loss-of-function snr1
genotypes (snr1E1/snr1R3) result in a more severe extra vein phenotype,
where a second extra vein is present posterior to L5. (E–F) Overexpression
of the brm dominant-negative allele brmK804R in a wild-type background
using the 69B GAL4 driver at 18jC results in the loss of distal portions of the
L5 vein and deletion of the pcv. (G–H) Overexpression of brmK804R in a
heterozygous snr1E1/+ background using the same 69B GAL4 driver at 18jC
results in suppression of the L5 and pcv vein loss normally observed.
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Antibody and histochemical staining
Wing imaginal discs from third instar Oregon-R larvae
were dissected in PBS, fixed, and immunostained with a-
SNR1 (1:500), a-BRM (1:200), and a-blistered/SRF anti-
bodies (1:250; Geneka) as previously described (Zraly et al.,
2003). Oregon-R pupae were dissected 24–28 h after pu-
parium formation (APF) in PBS and fixed overnight at 4jC
in 1% glutaraldehyde. Pupal wings were then freed from
their cuticular envelope in PBT (PBS, 1% Triton X-100) and
stained using the same protocol as discs (Zraly et al., 2003),
using a-SNR1 (1:2000), a-BRM (1:500), and a-blistered/
SRF (1:500) antibodies.
Third instar larval discs and pupal wings were dissected
and fixed as above for histochemical staining. h-Galactosi-
dase activity was detected as previously described (Johannes
and Preiss, 2002) allowing third instar discs to stain for 20–
30 min and pupal wings to stain overnight. Pupal wings were
similarly dissected and fixed for detection of h-galactosidase
activity, followed by extensive washing in 1  PBS/1 mM
EDTA and immunostaining using either a-SNR1 or a-BRM
antibodies.
Yeast interaction trap assays
A full-length net cDNA was obtained by PCR (ExTaq;
Takara, Inc.) amplification from a Drosophila E-ZAP cDNA
library (Stratagene) with the primers 5VCGGGATCC-
CGTCCTTCGCGGCTATGGCGAATA3V and 5VCCGC-
TCGAGCGGCAGAAATCAGTCGCATTTAAAGTCT.
Full-length NET (aa2–365) was fused to the LexA DNA
binding domain by inserting BamHI/XhoI net PCR fragments
into the backbone of the LexA yeast bait vector PEG202.
Deletion of the NET DNA binding domain (DHLH) was
constructed by cutting the full-length LexA:NET fusion
plasmid with SalI, which cuts both the net cDNA 3V terminus
and the vector polylinker sequence, resulting in a NET fusion
protein lacking amino acids 269–365. The B42 activation-
tagged SNR1 fusions used as prey have been described (Zraly
et al., 2003). Yeast mating and lacZ plate assays were
performed using standard procedures (Finley and Brent,
1994).Results
Reciprocal wing patterning phenotypes associated with snr1
and brm mutations
Impairment of snr1 or brm function leads to opposite
wing vein phenotypes (Fig. 1). Notably, the snr1E1 mutant
exhibits ectopic vein material emanating from the posterior
cross-vein (pcv) and posterior to the L5 longitudinal vein(Fig. 1B). This phenotype is sensitive to snr1 dosage (Figs.
1C, D), as it is enhanced in a snr1 null mutant background
and suppressed by additional copies of the wild-type snr1
gene (Marenda et al., 2003). Therefore, within the context of
wing vein development, the dominant ectopic veins associ-
ated with the snr1E1 allele represent a loss-of-function
phenotype, revealing an important role for snr1 function
in repressing vein development in intervein cells. In con-
trast, expression of a dominant-negative brmK804R transgene
(Brm-DN) results in shortening of the distal L5 vein and loss
of the posterior cross-vein (Figs. 1E, F), indicating that brm
function is normally required for vein development. Loss of
brm function, either using amorphic brm2 or dominant-
negative brmK804R alleles, strongly suppressed the snr1E1
ectopic veins. Importantly, both types of alleles show
comparable suppression of the snr1E1 wing phenotypes
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true loss-of-function effect in the wing disc. We next exam-
ined the effect of snr1 mutations (snr1E1 and a null allele,
snr1R3) on the shortened vein phenotype associated with
brmK804R overexpression. Both snr1 alleles strongly sup-
pressed the brmK804R phenotype (Figs. 1G, H). These snr1
and brm alleles produce stable proteins that are incorporated
into the Brm complex (Elfring et al., 1998; Marenda et al.,
2003); thus, both mutant alleles produce defective subunits
that allow for Brm complex formation, but the resultant
complexes are impaired or deficient in specific complex
functions.
There are several possible explanations for the reciprocal
genetic relationship between snr1 and brm in the develop-
ment of the wing veins. These might at least include that
possibility that the SNR1 and BRM proteins were differen-
tially expressed as has been found in leg imaginal discs
(Zraly et al., 2003), or that there is differential cell type-
specific regulation of common target genes in adjacent cells
(vein versus intervein). We first examined the distribution of
SNR1 and BRM in the developing larval wing discs and
pupal wings by immunolocalization using affinity-purified
antibodies. In close correspondence, both were found to be
abundantly expressed throughout the third instar larval wing
disc, including the areas of presumptive vein and intervein
tissues within the wing pouch (Zraly et al., 2003, data not
shown). Examination of early pupal wings (0–24 h after
puparium formation [APF]) revealed a similar wide distri-
bution of SNR1 and BRM, with strong expression in
intervein tissues and pro-vein nuclei (data not shown). At
24–28 h APF, both proteins are present in cells throughout
the wing with elevated expression in anterior regions
corresponding to the intervein compartments between L2/
L3 and L3/L4. Importantly, in regions of the wing sensitive
to disruption of both snr1 and brm, the proteins are present at
similar levels in both vein and intervein cells (Figs. 2B, C).
Thus, the opposite mutant phenotypes of snr1 and brm in
wings are not due to differential expression, but rather to
unique requirements for Brm complex activities, perhaps on
common promoter targets, in neighboring cells.Fig. 2. Expression of SNR1 and BRM proteins in the posterior cross-vein
region of pupal wings dissected 24–28 h after puparium formation (APF).
(A) No primary antibody control. (B) BRM staining shows expression of
BRM protein in intervein cells near the pcv as well as weak staining in vein
cells. (C) SNR1 staining shows patterns similar to BRM with expression in
both intervein cells and weak expression in vein cells. The positions of the
posterior cross-vein (pcv) and longitudinal L4 and L5 veins are indicated.The snr1E1 phenotypes and global regulators of gene
expression
The Drosophila Brm complex is involved in globally
regulating gene transcription through associations with
RNA Polymerase II (Armstrong et al., 2002; Zraly et al.,
2003). Based on functions in maintaining active transcrip-
tion of the homeotic (HOM) genes, components of the
Brm complex are classified as members of the trithorax
group of activators (Trx-G) (Kennison, 1995; Simon and
Tamkun, 2002). The Trx-G maintains active transcription
through functionally antagonizing gene repression mediat-
ed by components of the Polycomb group (Pc-G). We
therefore employed a candidate genetic screen looking for
dominant modification of the heterozygous snr1E1 extra
wing vein phenotype to determine if the phenotype was a
specific effect of misregulating the activities of the Brm
complex or a global manifestation of disrupting Trx-G or
Pc-G functions.
Although mutations in genes encoding other components
of the Brm complex show strong dominant interactions
with the snr1E1 phenotypes (Marenda et al., 2003), a small
number of mutations in Trx-G and Pc-G genes dominantly
modified the snr1E1 extra vein phenotype. These effects
were usually unique, perhaps reflecting specific roles of the
Brm complex within defined regions of the Drosophila
wing (Table 1). Among the Trx-G genes tested, mutations
in kismet and corto strongly enhanced the snr1E1 extra vein
phenotype, mutations in grappa showed strong suppres-
sion, and alleles of trx, ash1, RpII215, taf1, Dll, and lawc
had no significant effect. Although E(z) and Asx mutations
showed strong interactions with snr1E1, most Pc-G genes,
including Pc, Scr, Pcl, Psc, and Su(z)2, exhibited either no
effect or interactions were not consistent among different
alleles. Although the antimorphic E(z)60 allele enhanced the
snr1E1 wing phenotype, E(z) appears to function variably as
either a Trx-G or Pc-G gene (LaJeunesse and Shearn,
1996). Thus, the Brm complex plays a specific and impor-
tant role in regulating vein and intervein-specific gene
expression.
Identification of potential Brm complex targets
The genetic hierarchy guiding wing patterning is subject
to temporal requirements superimposed on spatial con-
straints. Genes required for elaboration of the vein pattern
are activated during larval development, then expression
patterns are refined and maintained during pupal growth
(Sturtevant and Bier, 1995). The wing development period
most sensitive to loss of snr1 function is early metamor-
phosis (0–24 h APF) as defined by temperature shift
experiments with snr1E1 (Marenda et al., 2003).
To identify potential target genes regulated by the Brm
complex, we employed a candidate genetic screen approach
looking for dominant modification (enhancement and sup-
pression) of the heterozygous snr1E1 phenotype. In general,
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Table 1
Enhancement and suppression of the snr1E1 extra wing vein phenotype
Trithorax group genea Allele Effect at 29jC
ash1 (absent, small 4(antimorph) no effectb
or homeotic1) 17(antimorph) partialb
22(amorph) partialb
trx (trithorax) E2(amorph) no effectc
1(hypomorph) no effect
corto 07128b(recessive lethal) enhancement(+++)
l1(recessive lethal) enhancement(+)
tsT18(conditional lethal) enhancement(++)
Df(3R)6-7(deficiency) enhancement(+)
lawc (leg, arista, EF250(lethal) enhancement(+)
wing complex) P1(viable) no effect
gpp (grappa) 61A(recessive lethal) suppression(+++)
XXV(recessive lethal) suppression(+++)
94A(hypomorph) suppression(+)
Distal-less (Dll) 5(lethal recessive) no effect
9(hypomorph) no effect
kismet (kis) 1(loss-of-function) enhancement(+++)
k13416(recessive lethal) enhancement(+++)
groucho (gro) C105(semi-viable) enhancement(++)
1(hypomorph) no effect
RpII215 (RNA 8(recessive lethal) enhancement(+++)
Polymerase II) 3(recessive lethal) enhancement(+)
1(amorph) no effect
Taf1 (TBP-associated EP421(viable) no effect
factor 1) 1(recessive lethal) no effect
XS-2232(recessive lethal) no effect
Polycomb group gene Allele Effect
E(z) (enhancer of zeste) 60(antimorph) enhancement(+++)
Hsc70-4 (Hsp70 03550(P allele) enhancement(++)
cognate 4) L3929(P allele) no effectd
Pcl (Polycomblike) 11(amorph) no effect
Pc (Polycomb) 4(loss-of-function) no effecte
In(3R)Pc3(amorph) suppression(+++)e
1(amorph) no effecte
Sce (Sec combs extra) D1(recessive lethal) no effect
Psc (Posterior sex combs) 1(hypomorph) partialf
e22(gain-of-function) no effect
Su(z)2 (suppressor
of zeste 2)
1.a1(loss-of-function)
1(gain-of-function)
no effect
no effect
Scr (sex combs reduced) 7(hypomorph) no effect
17(loss-of-function) no effect
Asx (additional sex combs) 1(gain-of-function) suppression(+++)g
Scm (sex comb on midleg) D1(amorph) no effect
Wing morphology
regulator
Allele Effect
net (net) 1(loss-of-function) enhancement(+++)
Df(2L)net62(Deficiency) enhancement(+++)
px (plexus) 72(loss-of-function) enhancement(+++)
rho (rhomboid) ve-1(loss-of-function) suppression(+++)h
vn (vein) C221(recessive lethal) no effecti
Egfr (epid. growth
factor recep.)
E1(hypermorph) enhancement(+++)
Dl (Delta) 9P(amorph) enhancement(+++)j
6B(hypomorph) enhancement(+++)j
bs (blistered) 2(visible recessive) enhancement(+++)
k07909(recessive lethal) enhancement(+++)
Df(2R)Px2(deficiency) enhancement(+++)
03267(recessive lethal) enhancement(+++)
P1292 (recessive lethal) enhancement(+++)
1348(viable) no effect
Table 1 (continued )
Wing morphology
regulator
Allele Effect
sbb (scribbler) 04440(recessive lethal) enhancement(+++)
tkv (thick veins) 1(hypomorph/conditional) enhancement(+++)k
k16713(hypomorph) no effect
dpp (decapentaplegic) s1(visible recessive) suppression(+++)j
d-ho(loss-of-function) suppression(++)m
N (Notch) Ax-tsl(gain of function) suppression(+++)
en (engrailed) 4(recessive lethal) no effect
H (Hairless) 2(amorph) suppression(+++)n
Me (Moire) 1(recessive lethal) no effect
ex (expanded) 697(visible recessive) enhancement(+++)
S (Serrate) 1(visible) suppression(++)
Ly (Lyra) 1(gain of function) suppression(+++)
cv (crossveinless) 1(visible recessive) enhancement(+++)
kni (knirps) ri-1(visible recessive) no effect
S (Star) 1(recessive lethal) suppression(+++)o
E(spl) (Enhancer of split) 1(visible dominant) no effect
ab (abrupt) 1(visible recessive) enhancement(+)
caup (caupolican) Df(3L)iro-2(deficiency) suppression(+++)
ara (araucan) Df(3L)iro-2(deficiency) suppression(+++)
sd (scalloped) 1(hypomorph) no effect
a Mutations in Brm complex genes are reported elsewhere (Marenda et al.,
2003).
b No effect on wing phenotype or longevity as ash14, snr1R3/snr1E1. ash117/
snr1E1 and ash122/snr1E1 wings showed suppression of the extra vein
extending distally from the posterior cross-vein, but showed enhanced extra
vein tissue posterior of the L5 wing vein.
c No effect on wing phenotype or longevity as trxE2, snr1R3/snr1E1.
d Hsc70-4L3929/snr1E1 show incomplete L5 vein (18%, n = 60).
e Pc4/snr1E1 showed incomplete L3, L4, L5 veins (9%, 42%, 37%,
respectively, N = 43) and moderate curling and disruption of the wing along
the posterior wing margin. Pc4/brm2 showed incomplete L3 (15%, N = 74).
Pc4, rhove/rhove enhanced incomplete rhove phenotype in L3 only.
In(3R)Pc3/snr1E1 showed incomplete L3, L4, and L5 (17%, 61%, and
57%, respectively, N = 70), and severely curled and disrupted wings along
the posterior wing margin. Pc1/snr1E1 showed incomplete L2, L4, L5 (6%,
38%, and 22%, respectively), and moderately curled and disrupted wings
along the posterior wing margin.
f Psce22/snr1E1 wings showed an extra vein between L3 and L4 44% of the
time (n = 54).
g snr1E1/Asx1 wings showed an extra vein between L3 and L4 11% of the
time (n = 44).
h rhove, snr1R3/rhove, snr1E1 showed total suppression of strong snr1
phenotype. brm2, rhove/rhove enhanced incomplete rhove phenotype in L5
only.
i snr1E1/vnC221 wings showed a weak increase in the number of deleted or
incomplete anterior cross-veins compared to vnC221/+ siblings (from 5% to
15%, n = 122).
J Dl9P/snr1E1 and Dl6B/snr1E1 enhanced Delta thick vein phenotype
especially near distal tips of L3, L4, and L5. Dl9P, snr1R3/snr1E1 showed
further enhancement of the Delta thick vein phenotype.
k tkv1/tkv1; snr1E1/+enhanced tkv thick vein phenotype at 25jC. tkv1/tkv1;
snr1E1/snr1E1 further enhanced tkv thick vein phenotype at 25jC.
l dpps1/dpps1; snr1E1/snr1R3 showed suppression of strong snr1 extra vein
phenotype and enhancement of dpp loss of vein phenotype in L5.
m dppd-ho/dppd-ho; snr1E1/snr1R3 showed suppression of strong snr1 extra
vein phenotype.
n snr1E1 suppressed the incomplete L4 vein phenotype of H2 mutants.
o snr1E1/S1 showed no effect on the dominant Star rough eye phenotype.
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genes dominantly suppressed the snr1E1 phenotypes, while
loss-of-function mutations in vein repressing genes showed
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hancement by recessive mutations in both the crossveinless
(cv) and abrupt (ab) genes (Figs. 3B, C) that typically
exhibit loss of the cross-veins and distal portions of L5,
respectively. The enhancement of snr1E1 by cv and ab
reveals previously unknown roles for these genes in repres-
sing vein formation in intervein cells. Moreover, the snr1E1
ectopic veins formed despite the absence of posterior cross-
veins (pcv) in a cv mutant, indicating that the ectopic veins
were formed before the development of the pcv, and the
veins were not extensions of, or dependent on, signaling
from existing pcv cells. In contrast, snr1E1 strongly en-
hanced the extra vein phenotypes associated with mutant
alleles of Delta (Dl), thick veins (tkv), and blistered (bs),
suggesting a possible role for the Brm complex in regulating
these genes or their targets (Figs. 3D, G, K).
Expression of the bs gene is critical for the development of
intervein cells during both larval and pupal growth, and bs
encodes a Drosophila homologue of the mammalian serum
response factor (DSRF) (Fristrom et al., 1994; Montagne et
al., 1996). Genetic interactions between snr1 and bs mutants
showed strong extra vein phenotypes reminiscent of reduced
functions associated with either snr1 or bs alone (Table 1 andFig. 3. Genetic interactions between snr1E1 and candidate enhancer and suppresso
snr1E1, (E) px72/+; snr1E1/+, (F) bs2/+, (G) bs2/+; snr1E1/+, (H) bs2/+; brm2/+, (I) b
tkv1/tkv1; brm2snr1E1/+ at 18jC.Fig. 3) (Fristrom et al., 1994). Mutations in brm partially
suppressed the bs2 and bsP1292 extra vein phenotypes (Fig. 3H
and data not shown) as well as the snr1E1, bs2 and snr1E1,
bsP1292 trans-heterozygous phenotypes (Fig. 3I and data not
shown), suggesting that bs expression may be regulated by
Brm complex activities. In addition to bs, the decapentaple-
gic (dpp) and thick veins (tkv) genes are critical for wing vein
development specifically during pupariation (de Celis, 1997).
DPP is a TGF-h homologue and TKV, a Type I TGF-h
receptor, mediates the transduction of DPP signals into cells.
Mutations in both dpp and tkv strongly interacted with snr1E1.
Loss-of-function mutations in dpp (dppS1,dppho) suppressed
the snr1E1 phenotype (Table 1). Conversely, snr1E1 enhanced
a hypomorphic tkv1 phenotype at 18jC where the tkv1
phenotype is strongest, and also at 25jC where the snr1E1
phenotypes are more fully penetrant (Table 1 and Figs. 3J, K).
Reduced brm function had no effect on the dpp phenotypes;
however, an amorphic allele of brm was able to partially
suppress both the homozygous tkv1 extra vein phenotype
(data not shown), as well as the interaction between snr1E1
and tkv (Fig. 3L).
Based on the genetic interactions observed, we examined
the expression of various genes in larval wing discs andr mutants. (A) snr1E1/+, (B) cv1/Y; snr1E1/+, (C) ab1/+; snr1E1/+, (D) Dl9P/
s2/+; brm2snr1E1/+, (J) tkv1/tkv1 at 18jC, (K) tkv1/tkv1; snr1E1/+ at 18jC, (L)
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either immunolocalizations of BS or a bs-lacZ transcriptional
reporter (Fristrom et al., 1994), was found to be restricted to
the presumptive intervein cells in wild-type third instar larval
wing discs and pupal wings (Figs. 4A, D) (Montagne et al.,
1996). Weak ectopic BS expression was initially observed in
the presumptive L5 vein of third larval instar wing discs
following overexpression of the brmK804R transgene (Brm-
DN, Fig. 4B), and this misregulation persisted in pupal wings
(Fig. 4E). In contrast, BS expression was unaffected in
snr1E1/snr1R3 larval wing discs (Fig. 4C). However, in
snr1E1/snr1R3 pupal wings, bs-lacZ expression was reduced
in intervein cells (Fig. 4F). Thus, brm function is required for
the repression of bs during larval development in the L5 pro-
vein cells, while snr1 is required to maintain bs expression in
intervein cells during early pupariation, in close agreement
with the snr1E1 temperature sensitive period.
Analysis of dpp and tkv expressions in third instar larval
wing discs of both snr1 and brm mutants using the enhancer
trap lines dpp-lacZdpp.BS3.0RA (Blackman et al., 1991) and
tkv-lacZk16713 revealed no change in expression from wild
type (data not shown). During pupal development, dpp is
restricted to the developing wing veins (Fig. 4G), while tkv isFig. 4. Effects of reduced snr1 and brm function on the expression of blistered (bs)
that BS expression in third larval instar wild-type (WT) wing discs is restricted to
overexpression of UAS-brmK804R using the GAL4-69B driver at 18jC results in ec
expression remains normal in snr1E1/snr1R3 wing discs. (D–L) Pupal wings (24–
intervein regions. (E) Ectopic BS expression persists in Brm-DN pupal wings ne
expression (arrowhead) is observed in snr1E1/snr1R3 pupal wings, as examined usin
examined using enhancer trap lines dpp-lacZdpp.BS3.0RA and tkv-lacZ k16713. (G
Expression of dpp in the distal L5 vein and the pcv is lost in Brm-DN pupal wing
regions distal to the pcv and posterior to wing vein L5, consistent with cells that fo
restricted to boundary intervein cells and along the wing margin. (K) Ectopic tkv e
expression is undetectable in the pcv region of Brm-DN pupal wings. (L) Ectop
intervein cells near the formation of the extra veins (inset white arrowheads) in shighly expressed in the presumptive boundary intervein cells
(Fig. 4J) (de Celis et al., 1997). Expression of Brm-DN in
pupal wings lead to the loss of dpp expression in L5 pro-vein
cells (Fig. 4H), while tkv was inappropriately expressed in
distal L5 pro-vein cells and lost in areas near the pcv (Fig.
4K). Conversely, in snr1E1/snr1R3 pupal wings, dpp expres-
sion was ectopically expressed both posterior to L5 and near
the pcv (Fig. 4I), in areas consistent with the formation of the
extra wing veins in snr1E1/snr1R3 mutants. As a possible
consequence, expression of tkv was upregulated in the
boundary cells that inappropriately expressed dpp in the
interveins (Fig. 4L). These results suggest that the Brm
complex either directly regulates the expression of dpp
and/or tkv during early pupal development, or that dpp and
tkv are misregulated in snr1 and brm mutants in response to
changes in the expression of other genes, such as bs, in third
instar larval wing discs.
SNR1 and NET interact to repress pupal rhomboid
expression through blocking the ATPase activity of BRM
The rhomboid (rho) gene, encoding a serine protease, is
normally expressed in all cells that develop as vein tissue, decapentaplegic (dpp), and thick veins (tkv). (A) Antibody staining reveals
presumptive intervein regions. (B) Loss of brm function (Brm-DN) through
topic BS expression in the presumptive L5 vein region (arrowhead). (C) BS
28 h APF). (D) BS wild-type expression remains restricted to presumptive
ar the distal L5 vein and pcv regions (black arrowhead). (F) Reduced bs
g the bs-lacZ line bsP1292. (G–L) Expression of dpp and tkv expression was
) Wild-type dpp expression is restricted to presumptive vein cells. (H)
s. (I) Ectopic dpp staining in snr1E1/snr1R3 pupal wings occurs in intervein
rm extra veins in this genotype (see Fig. 1C). (J) Wild-type tkv expression is
xpression is observed along the posterior wing margin (arrowhead), and tkv
ic tkv expression is observed in intervein cells that will become boundary
nr1E1/snr1R3 pupal wings.
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both dpp and tkv function to either maintain rho expression
in pro-vein cells (in the case of dpp) or to repress rho
expression in boundary intervein cells (in the case of tkv)
(de Celis et al., 1997); thus, the Brm complex may also be
required to directly regulate rho expression during this time.
To address this possibility, we first analyzed genetic inter-
actions between snr1 and brm loss-of-function mutants in
combination with rhove (an allele that results in shortened or
missing veins). Second, rho expression was measured in
snr1 and brm mutant pupal wings using the rho-lacZX81
enhancer trap line (Johannes and Preiss, 2002). rhove/rhove
wings show extensive loss of vein tissue (Fig. 5A) (Sturte-
vant et al., 1993). The amorphic brm2 allele enhanced the
rhove vein reduction phenotype, specifically in the L5 vein
(Fig. 5B), while snr1E1/snr1R3 suppressed the rhove pheno-
type in L5 (Fig. 5C). Further, the strong extra vein phenotype
associated with snr1E1/snr1R3 was also suppressed by the
presence of the rhove allele (compare to Figs. 1C, D).
Importantly, snr1E1 was able to suppress the shortened L5
vein resulting from interaction between rhove and brm2 (Fig.
5D), similar to its ability to suppress the loss of veins
associated with expression of the Brm-DN (Fig. 1). There-Fig. 5. Genetic and expression analysis of rhomboid (rho) in snr1 and brm
mutant wings. (A) Homozygous rhove/rhove adult wings show incomplete
L2, L3, L4, and L5 veins. (B) Reduced brm function leads to L5-specific
enhancement of the rhove phenotype (arrowhead—compare with A). (C)
Reduced snr1 function suppresses the rhove phenotype. Recombinant
snr1E1rhove/snr1R3rhove adult wings show a suppression of the rhove
phenotype in the L5 vein (arrowhead), and the rhove suppresses the snr1E1/
snr1R3 extra veins (compare to Fig. 1C). (D) brm2rhove/snr1E1rhove. Note
the L5-specific suppression of the brm, rho interaction (compare with B).
(E–G) Expression of rho in 24–28 h APF pupal wings as revealed by the
enhancer trap line rhoX81. (E) Wild-type rho expression is restricted to the
developing vein cells. (F) Ectopic rho expression occurs in snr1E1/snr1R3
pupal wings in intervein cells consistent with the formation of the extra
veins in mutant adult wings. (G) Loss of rho expression occurs in the distal
L5 vein of Brm-DN pupal wing veins.fore, rho may be a potential target of differential regulation
by the Brm complex in vein and inter vein cells.
While the expression of rho is normally restricted to the
pro-vein cells during pupal development (Fig. 5E) (Sturte-
vant et al., 1993), in the snr1E1/snr1R3 mutant combination,
ectopic rho expression was detected in intervein cells pos-
terior to wing vein L5 and near the pcv (Fig. 5F), in regions
consistent with the formation of the extra veins in snr1E1
mutant wings. Conversely, rho was not detected in distal
regions of the L5 vein in pupal wings expressing Brm-DN
(Fig. 5G). Thus, during pupal development, brm function
appears to be important to maintain rho expression in vein
cells, while snr1 function is necessary to prevent rho
expression in intervein cells.
The differential ability of the Brm complex to function
as either an activator or repressor of rho expression in
adjacent wing cells (vein vs. intervein) suggested the
likelihood that localized factors were responsible for direct-
ing the different activities of the Brm complex. In addition
to bs, another candidate for a localized intervein repressor is
the product of the net gene, encoding a nuclear protein
localized to the intervein cells where it represses rho
expression (Brentrup et al., 2000). Genetic interactions were
examined between alleles of net, including a chromosomal
deletion Df(2L)net62 and a hypomorph net1, and mutant
alleles of Brm complex components (Table 2 and Fig. 6).
Heterozygous net mutants have wings that appear essen-
tially wild type, with infrequent and weak pattern defects
(Table 2 and Figs. 6A, B); however, stronger loss of net
function leads to ectopic veins in intervein regions, associ-
ated with increased expression of rho (Brentrup et al.,
2000). While genetic combinations that included mutant
alleles of snr1, osa, and mor together with net resulted in
strong extra vein phenotypes (Figs. 6C–F), there was no
detectable effect on net phenotypes when brm function was
reduced using either brm2 or Brm-DN (Fig. 6G and Table
2), and brm mutants were able to suppress the snr1E1–net1
interaction phenotype (compare Fig. 6C with 6H). Our data
suggests that snr1 genetically collaborates with net to
restrict the expression of rho and that the appearance of
ectopic veins in snr1, net heterozygotes is dependent on
increased Brm complex ATPase activities.
We previously observed that reduced histone deacetylase
(HDAC) function enhanced the snr1E1 vein phenotypes
(Zraly et al., submitted for publication); further, mammalian
INI1 collaborates with HDACs to repress cyclin D1 in cell
lines derived from rhabdosarcomas (Zhang et al., 2002).
HDAC activities are associated with covalent modification
of histones, resulting in a localized chromatin structure
refractory to activation by RNA Polymerase II (Becker and
Horz, 2002; Kuo and Allis, 1998). Mutations in Drosophila
HDAC genes, Hdac1/Rpd3, and Hdac3 enhanced the ap-
pearance of ectopic veins associated with net alleles (Figs.
6I, J), supporting the view that net genetically functions with
snr1 and Hdac to maintain repression of rho in intervein
cells.
Table 2
Genetic interactions between net and Brm complex subunits
Genotype No. of Severity of phenotypea
wings
examined
 + ++
[net1]
net1/+ 198 97 3 –
net1/+; snr1R3/+ 188 42 43 15
net1/+; snr1E1/+ 114 13 29 58
brmK804R/+; net1/+;
snr1E1/+
92 41 33 26
brmK804R/brmK804R;
net1/+; snr1E1/+
68 84 6 10
brmK804R/+; net1/+ 90 76 24 –
brmK804R/brmK804R;
net1/+
108 98 2 –
net1/+; brm2/+ 144 100 – –
net1/+; osa00090-eld/+ 104 100 – –
net1/+; osa2/+ 116 44 44 12
net1/+; mor1/+ 102 48 30 22
net1/+; Df(3R)sbd105,
pp, Ubxbx-1, sr1,
es/+ [mor]
92 93 7 –
net1/+; Df(3L)ZN47
[E(brm) 64E1-65C]
102 27 53 20
Df(1)c246/+; net1/+
[BAP60]
80 84 16 –
[Df(2L)net62]
Df(2L)net62/+ 164 88 12 –
Df(2L)net62/+; snr1R3/+ 138 20 44 36
Df(2L)net62/+; snr1E1/+ 132 – 34 66
brmK804R/+; Df(2L)net62/+ 92 85 15 –
brmK804R/brmK804R;
Df(2L)net62/+
76 100 – –
Df(2L)net62/+; brm2/+ 88 95 5 –
Df(2L)net62/+; osa00090-eld/+ 98 3 97 –
Df(2L)net62/+; osa2/+ 72 45 44 11
Df(2L)net62/+; mor1/+ 68 31 50 19
Df(2L)net62/+; Df(3R)sbd105,
pp, Ubxbx-1, sr1, es/+
50 60 30 10
Df(2L)net62/+; Df(3L)ZN47 66 11 36 53
Df(1)c246/+; Df(2L)net62/+ 62 71 29 –
a Severity of wing phenotypes was scored as follows: () normal vein
pattern, (+) single extra vein near posterior cross-vein, (+) two or more extra
veins near posterior cross vein and posterior to longitudinal vein L5.
Fig. 6. Genetic interactions among Brm complex genes, net, and HDACs.
(A) net1/+, (B) Df(2L)net62/+, (C) net1/+; snr1E1/+, (D) net1/+; snr1R3/+, (E)
net1/+; mor1/+, (F) Df(2L)net62/+; osa2/+, (G) Df(2L)net62/+; brm2/+, (H)
Brm-DN/Brm-DN; net1/+; snr1E1/+, (I) Df(2L)net62/+; Hdac3B/+, (J) net1/+;
Rpd304556/+. Note that in panel H, the Brm-DN (brmK804R) is expressed
from the native brm promoter (Elfring et al., 1998).
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direct repressor of rho and net genetically collaborates with
snr1 in repressing vein formation in intervein cells, we used
yeast two hybrid analyses to examine whether this interaction
might be accomplished through a physical association be-
tween the two proteins (Fig. 7). A portion of NET
(NETDHLH) fused to the LexA-DNA binding domain
(LexA-DB) showed strong and specific interactions with a
full-length (aa15–370) SNR1-B42 activation domain con-
struct, assayed with two independent reporter genes in yeast.
The NET-SNR1 interaction required the presence of two
imperfectly repeated regions within SNR1, termed Repeat 1
and Repeat 2 (Dingwall et al., 1995; Morozov et al., 1998), as
deletions of either repeat region showed a weakened interac-
tion. The NET (DHLH) also showed strong interaction withSNR1E1 (aa15–370/TS) in this assay. A full-length NET-
LexA fusion that included the NET bHLH DNA binding
domain was unable to interact with the SNR1 fusions,
suggesting that the DNA binding domain within NET either
interfered with the physical contacts in this assay or that the
presence of two different DNA binding domains within the
same protein fusion construct blocked or destabilized poten-
tial protein–protein or protein–DNA interactions. It is also
possible that our truncated NET fusion has removed an
inhibitory region present in the full-length protein. Our
results therefore suggest that the genetic interactions ob-
served between snr1E1 and netmutants are not solely a result
of loss of the ability of the SNR1E1 protein to associate with
Fig. 7. SNR1 and NET physically interact. Full length NET (FL) or NET lacking the basic helix-loop-helix DNA binding domain (DHLH) was fused to the
LexA-DNA binding domain (LexA-DB) and tested against full-length, deleted, and mutant SNR1 constructs fused to the B42 activation domain (B42-AD).
The positions of two highly conserved repeat domains within SNR1 (R1 and R2) as well as a coiled coil region (CC) are shown. Note that the repeat regions
(aa15–240 and aa240–370) are important for the association with NET, and that associations with the SNR1E1 mutant protein (aa15–370/TS) are not
detectably affected in this assay.
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interactions between these two proteins resulting in derepres-
sion of rho expression in intervein cells because of misregu-
lation of Brm complex ATPase activities.Discussion
ATP-dependent chromatin remodeling complexes have
been implicated in both gene activation and repression, often
in collaboration with gene-specific transcription factors and
other chromatin modifying complexes, such as histone
acetylases and deacetylases (Kingston et al., 1996; Peterson,
2002). Our results using a conditional allele of Drosophila
snr1, encoding a conserved counterpart of yeast SNF5 and
mammalian INI1, and an essential subunit of SWI/SNF
complexes suggest a mechanism for SWI/SNF-mediated
gene repression that relies on the function of one subunit
to block or shield the transcriptional activation functions of
the complex on specific gene targets in a subset of cells.
Identifying targets and cofactors of Brm complex regulation
What are the biologically important targets of the Brm
(SWI/SNF) complexes? How are they identified and regu-
lated? The Brm complex is important for the global regula-
tion of gene expression, as evidenced by the transcriptional
codependence of RNA Polymerase II with components of
the Brm complex and similar broad expression in actively
transcribed regions of larval salivary gland polytene chro-
mosomes (Armstrong et al., 2002; Collins et al., 1999; Zraly
et al., 2003). While the Brm complex may be bound at
multiple promoters along the chromosome, at any particular
location, it may be involved in promoting gene activation,
gene repression, or functioning to stabilize activator or
repressor binding independent of its chromatin remodelingactivity. The consequence of Brm association on individual
gene expression may also be a function of other factors or
complexes present at nearby sites or directly in contact with
the Brm complex.
Previous studies have used phenotypic analysis to deter-
mine functional target regulation of SWI/SNF complexes.
For example, the SWI/SNF genes were identified based on
their requirement for induced transcription of the yeast HO
(Stern et al., 1984) and SUC2 genes (Neigeborn and Carlson,
1984). More recently, in rhabdosarcoma tumor cell lines, the
mammalian INI1 gene was found to regulate cyclin D1
transcription, suggesting a possible mechanism for INI1-
mediated tumor suppression (Zhang et al., 2002). Genetic
analyses in flies led to the discovery that Brm complex
components regulated the pair-rule gene even-skipped (Treis-
man et al., 1997), the engrailed segmentation gene (Brizuela
and Kennison, 1997), HOM selector genes Scr (Tamkun et
al., 1992), Ubx (Collins and Treisman, 2000), and Antp
(Vazquez et al., 1999). Expression of UAS-Osa resulted in
repression of some Wingless (WG) target genes, including
nubbin, Distal-less, and decapentaplegic, and co-expression
of UAS-BrmK804R suppressed the effect (Collins and Treis-
man, 2000). In addition, expression of UAS-BrmK804R alone
resulted in increased expression of some WG targets. Thus,
the Brm complex is capable of directly repressing certain
genes in an ATP-dependent manner.
Reduced or impaired function of SNR1 within the Brm
complex leads to opposite phenotypes in the development of
the wing vein and intervein tissues inDrosophila, suggesting
that SNR1 constrains Brm complex activity in a cell-type
specific manner. One likely target of Brm complex regula-
tion (either direct or indirect) in both vein and intervein cells
is the blistered (bs) gene, encoding Drosophila serum
response factor (DSRF), which appears to be regulated both
positively and negatively. Blistered/DSRF is normally
expressed in larval wing discs throughout the presumptive
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ment of vein tissue, and it is required in a cell-autonomous
fashion to promote the development of intervein cells (Mon-
tagne et al., 1996). Reduced brm function in larval wing
discs allows for ectopic expression of bs in the presumptive
L5 vein cells, while bs is unaffected in snr1 mutants until
pupal development. As bs mutants strongly interacted with
snr1E1 and both are flightless with held-out-wings (Fristrom
et al., 1994; Marenda et al., 2003), components of the BS
pathway may collaborate with snr1 in intervein cells to block
expression of genes required for vein development. Another
possibility is that snr1 critically functions to maintain inter-
vein cell fate during metamorphosis, at least in part through
regulation of bs expression. Consistent with this view, we
previously found that the most critical temperature sensitive
period for snr1E1 was within 24 h after puparium formation
(Marenda et al., 2003) within the same developmental
window when the final wing vein pattern is elaborated.
In addition to bs, mutations in expanded (ex) and
scribbler (sbb) both showed dominant enhancement of the
snr1E1 extra vein phenotype. Similar to bs, mutant alleles of
ex and sbb exhibit wing patterning phenotypes individually
and all three were identified as modifiers of Merlin/NF-2
(LaJeunesse et al., 2001) that encodes the Drosophila
homologue of the Neurofibromatosis-2 tumor suppressor
gene. Merlin/NF-2 and EX are members of the Protein 4.1
superfamily, required for the regulation of cell proliferation
and differentiation, and they physically contact each other
through conserved residues (McCartney et al., 2000). Ge-
netic epistasis tests revealed that bs, ex, sbb, and Merlin
likely function together in a common pathway to regulate
wing development—both proliferation and differentiation—
perhaps via the DPP signaling pathway (McCartney et al.,
2000). Based on the genetic synergism between snr1, bs, ex,
and sbb, one possibility is that the BS/EX/SBB/Merlin
complex regulates the expression of genes required for
proper wing vein patterning during early metamorphosis
through downstream effects on chromatin structure mediat-
ed by the Brm complex.
Integrating Brm complex functions with vein-specific
genetic programs
The extra veins observed in snr1E1 were consistently
found to reside between the L4/L5 veins and posterior to L5,
in parallel with the existing longitudinal veins. The ectopic
veins between L4/L5 appeared to extend from the posterior
cross-vein (pcv); however, the ectopic veins were present in
crossveinless (cv) mutants, and thus were not dependent
upon signals emanating from existing pcv cells. In contrast,
the ectopic veins were found to be dependent on BRM
activity and derepression of rho. In fact, the rhove-reduced
vein phenotype was enhanced by reduced brm function and
suppressed by snr1E1 specifically in the L5 vein, suggesting
that the interactions are highly specific. What could account
for the elaboration of ‘new’ longitudinal veins in snr1mutants? It is intriguing that extra veins also form in the
same location in a variety of other wing patterning mutants
(Biehs et al., 1998). Prevailing models of wing vein devel-
opment propose that each wing vein develops according to a
specific genetic program (Bier, 2000). While the factors
required for L5 development are not well defined, it is clear
that the Brm complex is required in cells within and
bordering L5 to mediate proper signaling. Further, it has
been suggested that the extra veins observed in a variety of
wing patterning mutants arise because derepression of
ancestral ‘para-veins’ in the Drosophila wing, as the extra
veins correspond to locations of actual veins in the wings of
more primitive insects (Biehs et al., 1998). These para-veins
are also thought to occur by vein-specific genetic programs.
Thus, if the Brm complex is required for proper L5 vein
development, then it may also be required for elaboration of
the L4 and L5 para-veins, as the presumptive para-vein cells
are competent to form veins in response to inductive signals
that are normally blocked by BS, NET, and HDACs in
cooperation with SNR1. In snr1E1, these signals are effec-
tively transduced, allowing for vein formation because of
upregulated rho expression. Importantly, the ability of these
cells to adopt para-vein fate, rather than intervein character,
is dependent on Brm complex ATPase activities.
SNR1 assists in constraining Brm complex activities
Complete removal of a Brm complex subunit results in
late embryonic/early larval lethality, revealing the essential
nature of that subunit for full in vivo complex functions.
However, mutations that conditionally disrupt specific func-
tions of an individual subunit, while still enabling the
complex to assemble, allow for an unprecedented character-
ization of the unique contributions of that subunit. SWI/SNF
complex components were initially identified in yeast as
activators of transcription (Neigeborn and Carlson, 1984;
Stern et al., 1984), and more recently in gene repression as
well (Martens and Winston, 2002; Sudarsanam and Winston,
2000; Wang et al., 2002). The mechanisms by which the
SWI/SNF complexes can influence both gene activation and
repression in vivo are not fully understood (Peterson, 2002).
It is generally thought that gene activation involves recruit-
ment by sequence-specific activator proteins, with ATPase
activity of the SWI/SNF complexes facilitating a variety of
local chromatin changes to allow for transcriptional induc-
tion or maintenance by RNA PolII and associated factors.
Less clear are the mechanisms of SWI/SNF-mediated gene
repression, which in some cases appears to involve the
activities of HDACs as co-repressors (Harbour and Dean,
2000; Martens and Winston, 2003; Zhang et al., 2002).
Mechanisms to globally restrict SWI/SNF activating func-
tions may include shielding of large chromosomal regions
through the presence of linker histone H1 and/or the pres-
ence of Pc-G protein complexes (Peterson, 2002).
Several models exist that attempt to explain gene-specific
SWI/SNF-mediated repression. First, differential subunit
Fig. 8. Model for cell-specific Brm complex interactions to differentially
modulate expression of a potential target gene. An important feature of this
model is that components of the Brm complex, such as SNR1, cooperate
with differentially expressed gene-specific repressors (e.g., NET) to restrain
the Brm complex-mediated activation of potential target genes. In wing vein
cells (top), Brm complex-dependent activation of rhomboid occurs in the
absence of NET. Intervein cells express NET (bottom), which binds to
specific elements in the rhomboid control region and interacts with SNR1 to
shield the activation functions of the Brm complex, leading to repression of
rhomboid. The presence of SNR1E1 in Brm complexes affects the interaction
with NET, leading to ectopic expression of rhomboid in intervein cells.
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repression or activation functions. For example, certain
repressive forms of the mammalian hBRM and BRG-1
complexes contain components of the Sin3 repressor com-
plex (Sif et al., 2001), a component not normally found in
human core SWI/SNF complexes (Phelan et al., 1999). A
second model involves recruitment of the SWI/SNF com-
plex to promoters as components of larger co-repressor
complexes. In mammals, the hBRM/BRG-1 complexes
form co-repressors with retinoblastoma (pRB) and HDACs
to block cell cycle progression at the G1-S boundary
(Harbour and Dean, 2000; Luo et al., 1998; Zhang et al.,
2000). INI1, the mammalian SNR1 counterpart, represses
cyclinD1 expression in G1 through collaborations with
HDAC complexes (Zhang et al., 2002). Also, the tumor
suppressor gene prohibitin represses E2F-mediated tran-
scription by recruitment of BRG1 to E2F promoters (Wang
et al., 2002), again suggesting that SWI/SNF coordinates
with repressor proteins to actively repress gene expression.
A third model is that the SWI/SNF complex mediates gene
repression by directly altering nucleosome structure in an
ATP-dependent (SWI2/SNF2) manner to form a repressive
chromatin environment (Martens and Winston, 2002). In all
of these models, SWI/SNF actively represses gene expres-
sion, either directly through the ATP-dependent chromatin
remodeling functions of the complex itself, or as part of
large repressor complexes.
We present here a genetic argument for another mecha-
nism for Brm complex mediated repression that allows for
both activation and repression of the same gene target in
different cells (Fig. 8). Essential features of this model
include (i) the ability of a conserved core subunit (SNR1)
to functionally constrain the BRM ATPase subunit function
in a cell-specific and developmentally regulated manner; (ii)
the ability to block gene expression is dependent upon
interactions between conserved core components of the
Brm complex and gene-specific repressors; (iii) the activi-
ties of histone deacetylases are important to maintain the
repressed state, either through epigenetic imprinting or
blocking acetylation/binding by bromodomain proteins
(e.g., BRM).
Our model may help to explain the lineage-specific
tumors associated with disruptions of INI1. Bi-allelic loss
of INI1 is associated with almost every case of aggressive
rhabdosarcomas and approximately 45% of CD8+ T-Cell
lymphomas (Biegel et al., 2002; Sevenet et al., 1999a,b). In
addition, interactions among INI1, GADD34, and HRX/
ALL have been implicated in leukemic events and apoptosis
(Adler et al., 1999; Ae et al., 2002; Reincke et al., 2003).
Thus, the INI1/SNR1 subunit is important for potentiating
cell cycle and epigenetic maintenance functions of the
complex, most likely dependent on recruitment by either
activators or repressors (Cheng et al., 1999; Marenda et al.,
2003; Zraly et al., 2003). As our results demonstrate in vivo
functional requirements for the SNR1 subunit in constrain-
ing Brm complex ATPase activities in a cell-specific mannerand in distinct developmental contexts or tissues, it may be
that INI1 is serving similar ATPase restriction functions in
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